scholarly journals GH-Releasing Hormone Induces Cardioprotection in Isolated Male Rat Heart via Activation of RISK and SAFE Pathways

Endocrinology ◽  
2013 ◽  
Vol 154 (4) ◽  
pp. 1624-1635 ◽  
Author(s):  
Claudia Penna ◽  
Fabio Settanni ◽  
Francesca Tullio ◽  
Letizia Trovato ◽  
Pasquale Pagliaro ◽  
...  

Abstract GHRH stimulates GH synthesis and release from the pituitary and exerts direct effects in extrapituitary tissues. We have previously shown that pretreatment with GHRH reduces cardiomyocyte apoptosis and improves heart function in isolated rat hearts subjected to ischemia/reperfusion (I/R). Here, we determined whether GHRH given at reperfusion reduces myocardial reperfusion injury and investigated the molecular mechanisms involved in GHRH effects. Isolated rat hearts subjected to I/R were treated at the onset of reperfusion with: 1) GHRH; 2) GHRH+GHRH antagonist JV-1-36; 3) GHRH+mitochondrial ATP-dependent potassium channel inhibitor 5-hydroxydecanoate; 4) GHRH+mitochondrial permeability transition pore opener atractyloside; 5) GHRH+ phosphoinositide 3-kinase/Akt inhibitor Wortmannin (WM); and 6) GHRH+signal transducer and activator of transcription-3 inhibitor tyrphostin-AG490 (AG490). GHRH reduced infarct size at the end of reperfusion and reverted contractility dysfunction in I/R hearts. These effects were inhibited by either JV-1-36, 5-hydroxydecanoate, atractylosid, WM, or AG490. Western blot analysis on left ventricles showed GHRH-induced phosphorylation of either the reperfusion injury salvage kinases (RISK), phosphoinositide 3-kinase/Akt, ERK1/2, and glycogen synthase kinase-3β or signal transducer and activator of transcription-3, as part of the survivor activating factor enhancement (SAFE) pathway. GHRH-induced activation of RISK and SAFE pathways was blocked by JV-1-36, WM, and AG490. Furthermore, GHRH increased the phosphorylation of endothelial nitric oxide synthase and AMP-activated protein kinase and preserved postischemic nicotinamide adenine dinucleotide (NAD+) levels. These results suggest that GHRH protects the heart from I/R injury through receptor-mediated mechanisms, leading to activation of RISK and SAFE pathways, which converge on mitochondria and possibly on AMP-activated protein kinase.

2004 ◽  
Vol 82 (6) ◽  
pp. 409-416 ◽  
Author(s):  
Hernando Leon ◽  
Laura L Atkinson ◽  
Jolanta Sawicka ◽  
Ken Strynadka ◽  
Gary D Lopaschuk ◽  
...  

Ischemia-reperfusion injury in the heart results in enhanced production of H2O2 and activation of AMP-activated protein kinase (AMPK). Since mutations in AMPK result in cardiovascular dysfunction, we investigated whether the activation of AMPK mediates the H2O2-induced reduction in cardiac mechanical function. Isolated working rat hearts were perfused at 37 °C with Krebs-Henseleit solution. Following a 20-minute equilibration period, a single bolus of H2O2 (300 µmol/L) was added and the hearts were perfused for an additional 5 min. H2O2 induced a dramatic and progressive reduction in cardiac function. This was accompanied by rapid and significant activation of AMPK, an increase in Thr-172 phosphorylation of AMPK, and an increase in the creatine to phosphocreatine (Cr/PCr) ratio. Addition of pyruvate (5 mmol/L) to the perfusate prevented the H2O2-mediated reduction in cardiac mechanical dysfunction, activation of myocardial AMPK activity, increase in AMPK phosphorylation and the increase in the Cr/PCr ratio. Hearts challenged with H2O2 (300 µmol/L) in presence of either AMPK inhibitor Compound C (10 µmol/L) or its vehicle (dimethyl sulfoxide (DMSO), 0.1%) showed reduced impairment in cardiac mechanical function. Compound C but not its vehicle significantly inhibited myocardial AMPK activity. Thus, H2O2 induces cardiac dysfunction via both AMPK-dependent and independent mechanisms.Key words: oxidative stress, AMPK, antioxidant, isolated rat heart, pyruvate.


JAK-STAT ◽  
2014 ◽  
Vol 3 (2) ◽  
pp. e29554 ◽  
Author(s):  
Jayant Shravah ◽  
Baohua Wang ◽  
Marijana Pavlovic ◽  
Ujendra Kumar ◽  
David DY Chen ◽  
...  

FEBS Letters ◽  
2001 ◽  
Vol 505 (3) ◽  
pp. 348-352 ◽  
Author(s):  
Christophe Beauloye ◽  
Anne-Sophie Marsin ◽  
Luc Bertrand ◽  
Ulrike Krause ◽  
D.Grahame Hardie ◽  
...  

Life Sciences ◽  
2000 ◽  
Vol 67 (2) ◽  
pp. 101-112 ◽  
Author(s):  
Shinji Kaneko ◽  
Kenji Okumura ◽  
Yasushi Numaguchi ◽  
Hideo Matsui ◽  
Kichiro Murase ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document